Carvedilol hatása a szabadgyök indukálta adp-ribozilációra és vörösvértest membrán károsodásra

Translated title of the contribution: The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals

Tamás Habon, Eszter Szabados, Gábor Késmárky, Róbert Halmosi, Tibor Past, Balázs Sümegi, Kálmán Tóth

Research output: Contribution to journalArticle

1 Citation (Scopus)


Objective: Previous studies have reported that the beta and alpha adrenoceptor blocker carvedilol had unique protective effect on free radical induced myocardial injury. The aim of this study was to examine how carvedilol regulates ROI-mediated signaling and decreases RBC membrane damage in heart perfusion and rheological model. Methods: The ischemia-reperfusion induced oxidative cell damages, and changes in the intracellular signaling mediated by reactive oxygen species and peroxynitrite were studied on rats, in Langendorff heart perfusion system (n=15). The effect of carvedilol on red blood cell suspension viscosity (hematocrit: 60%) incubated with free radical generator (phenazine methosulphate) was also investigated (n = 10). The measurements were performed on a capillary viscosimeter, Results: In both studies a protective effect of carvedilol was found, as the decrease of red blood cell suspension viscosity and K+ concentration in the supernatant indicated. Carvedilol significantly decreased the ischemia-reperfusion induced free radical production and the NAD+ catabolism and reversed the poly- and mono Carvedilol also decreased the lipid peroxidation and membrane damages as determined by free malondialdehyde production and the release of intracellular enzymes, The self ADP-ribosylation of isolated PARP was also significantly inhibited by carvedilol. Conclusion: Our results show that carvedilol can modulate the ROI-induced signaling through poly- and mono-ADP-ribosylation reactions, the NAD+ catabolism in postischemic perfused hearts and has a marked scavenger effect on free radical generator induced red blood cell membrane damage. All these findings may play an important role in the beneficial effects of carvedilol treatment in different cardiovascular diseases.

Original languageHungarian
Pages (from-to)306-313
Number of pages8
JournalActa pharmaceutica Hungarica
Issue number3
Publication statusPublished - Dec 1 2001


ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this